BeOne Medicines (ONC)

BeOne Medicines (ONC) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

ONC Slips as Broader Market News Stays Quiet

BeOne Medicines is down 1.2% today, while the S&P 500 is up 0.3% and the Nasdaq 100 is down 0.4%. No fresh company catalyst stands out; traders are weighing recent earnings and the outlook for its cancer-drug business.

Published 2026-11-20 15:01:04 UTC.